Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

Nanjing Red Sun Co.,Ltd. (000525.SZ)

Compare
6.59
+0.09
+(1.38%)
At close: April 18 at 3:05:00 PM GMT+8
Loading Chart for 000525.SZ
  • Previous Close 6.50
  • Open 6.35
  • Bid 6.59 x --
  • Ask 6.60 x --
  • Day's Range 6.50 - 6.65
  • 52 Week Range 3.27 - 8.62
  • Volume 20,749,721
  • Avg. Volume 22,297,570
  • Market Cap (intraday) 8.554B
  • Beta (5Y Monthly) -0.32
  • PE Ratio (TTM) --
  • EPS (TTM) -0.44
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jul 19, 2019
  • 1y Target Est --

Nanjing Red Sun Co.,Ltd. engages in the research, manufacture, and sale of pesticides and other chemicals in China. The company offers herbicides, insecticides, fungicides, disinfectants, and three-drug intermediates, as well as fine chemicals. It also provides technical consultation and investment management and consultation services, as well as self-operated and agent Import and export business of commodities and technologies. Nanjing Red Sun Co.,Ltd. was founded in 1991 and is headquartered in Nanjing, China.

www.chinaredsun.com

2,918

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 000525.SZ

View More

Performance Overview: 000525.SZ

Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

000525.SZ
10.39%
SSE Composite Index (000001.SS)
2.24%

1-Year Return

000525.SZ
24.80%
SSE Composite Index (000001.SS)
6.59%

3-Year Return

000525.SZ
4.12%
SSE Composite Index (000001.SS)
2.54%

5-Year Return

000525.SZ
2.99%
SSE Composite Index (000001.SS)
15.44%

Compare To: 000525.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 000525.SZ

View More

Valuation Measures

Annual
As of 4/18/2025
  • Market Cap

    8.55B

  • Enterprise Value

    12.63B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.74

  • Price/Book (mrq)

    9.34

  • Enterprise Value/Revenue

    3.85

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -11.76%

  • Return on Assets (ttm)

    -3.86%

  • Return on Equity (ttm)

    -31.53%

  • Revenue (ttm)

    3.28B

  • Net Income Avi to Common (ttm)

    -385.82M

  • Diluted EPS (ttm)

    -0.44

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    253.79M

  • Total Debt/Equity (mrq)

    462.25%

  • Levered Free Cash Flow (ttm)

    157.42M

Research Analysis: 000525.SZ

View More

Company Insights: 000525.SZ

Research Reports: 000525.SZ

View More

People Also Watch